| ViiV Healthcare GmbH - Ziagen, Lösung zum Einnehmen | | 55049 | | 01 | | Ziagen | | Lösung zum Einnehmen | | J05AF06 | | Abacavir | | 28.06.1999 | | |
| | Composition | | abacavirum 20 mg ut abacaviri sulfas, sorbitolum liquidum cristallisabile 492 mg, natrii citras dihydricus, acidum citricum, propylenglycolum 50 mg, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, aromatica Bananenaroma cum propylenglycolum, aromatica Erdbeeraroma cum propylenglycolum, saccharinum natricum, propylis parahydroxybenzoas 180 µg, E 218 1.5 mg, ad solutionem pro 1 ml corresp. natrium 2.38 mg. | | Packungsbestandteile | | Solution (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Abacavir | 20 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Abacavir | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | Acidum Hydrochloridum aut Natrii Hydroxidum | | | | Aqua Purificata | | | | Aromatica Bananenaroma cum Propylenglycolum | | | | Aromatica Erdbeeraroma cum Propylenglycolum | | | | E 218 | 1.5 mg/ml | conserv. | | Natrii Citras Dihydricus | | | | Propylenglycol | 50 mg/ml | | | Propylis Parahydroxybenzoas | 180 µg/ml | | | Saccharinum Natricum | | | | Sorbitolum Liquidum Cristallisabile | 492 mg/ml | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 240 ml | 66.97 | 89.25 | A | LS | Oui |
|
|
